1. Home
  2. ABVX vs STKL Comparison

ABVX vs STKL Comparison

Compare ABVX & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • STKL
  • Stock Information
  • Founded
  • ABVX 2013
  • STKL 1973
  • Country
  • ABVX France
  • STKL United States
  • Employees
  • ABVX N/A
  • STKL N/A
  • Industry
  • ABVX
  • STKL Precious Metals
  • Sector
  • ABVX
  • STKL Basic Materials
  • Exchange
  • ABVX Nasdaq
  • STKL Nasdaq
  • Market Cap
  • ABVX 722.3M
  • STKL 850.0M
  • IPO Year
  • ABVX N/A
  • STKL N/A
  • Fundamental
  • Price
  • ABVX $6.16
  • STKL $7.29
  • Analyst Decision
  • ABVX Strong Buy
  • STKL Strong Buy
  • Analyst Count
  • ABVX 7
  • STKL 4
  • Target Price
  • ABVX $37.86
  • STKL $9.50
  • AVG Volume (30 Days)
  • ABVX 216.6K
  • STKL 536.5K
  • Earning Date
  • ABVX 09-09-2024
  • STKL 02-26-2025
  • Dividend Yield
  • ABVX N/A
  • STKL N/A
  • EPS Growth
  • ABVX N/A
  • STKL N/A
  • EPS
  • ABVX N/A
  • STKL N/A
  • Revenue
  • ABVX $9,676,417.00
  • STKL $711,683,000.00
  • Revenue This Year
  • ABVX $31.67
  • STKL $15.65
  • Revenue Next Year
  • ABVX $759.77
  • STKL $9.32
  • P/E Ratio
  • ABVX N/A
  • STKL N/A
  • Revenue Growth
  • ABVX 100.87
  • STKL 16.96
  • 52 Week Low
  • ABVX $5.54
  • STKL $4.88
  • 52 Week High
  • ABVX $17.02
  • STKL $8.11
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 30.30
  • STKL 46.88
  • Support Level
  • ABVX $5.54
  • STKL $7.14
  • Resistance Level
  • ABVX $6.46
  • STKL $7.90
  • Average True Range (ATR)
  • ABVX 0.51
  • STKL 0.28
  • MACD
  • ABVX -0.04
  • STKL -0.07
  • Stochastic Oscillator
  • ABVX 30.10
  • STKL 41.77

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks.

Share on Social Networks: